Andrew Huberman· PhD
one in 12 people which is a very high number is heterero heterozygus for congenital adrenal hyperlasia, meaning they have one mutant copy, one healthy copy.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
one in 12 people which is a very high number is heterero heterozygus for congenital adrenal hyperlasia, meaning they have one mutant copy, one healthy copy.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
It's one in 12. >> Huh. 1 in 12, which is seems like an outrageously high number, but it's one of the things that is immediately screened for, maybe not as much as some other, you know, blood related diseases and things like that.